M1331 – Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam

Long description

Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam

Short description

Pts eval ini xm 8 wks

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2024

Last change

January 1, 2024 – No change

Nearby M codes

• M1323 – Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
• M1324 – Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
• M1325 – Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)
• M1326 – Patients with a diagnosis of hypotony
• M1327 – Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
• M1328 – Patients with a diagnosis of acute vitreous hemorrhage
• M1329 – Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
• M1330 – Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
• M1332 – Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
• M1333 – Acute vitreous hemorrhage
• M1334 – Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
• M1335 – Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
• M1336 – Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
• M1337 – Acute pvd
• M1338 – Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
• M1339 – Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period